Matthew Rausch

998 total citations
11 papers, 54 citations indexed

About

Matthew Rausch is a scholar working on Oncology, Immunology and Physiology. According to data from OpenAlex, Matthew Rausch has authored 11 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 2 papers in Physiology. Recurrent topics in Matthew Rausch's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (3 papers) and Adenosine and Purinergic Signaling (2 papers). Matthew Rausch is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (3 papers) and Adenosine and Purinergic Signaling (2 papers). Matthew Rausch collaborates with scholars based in United States, Canada and South Korea. Matthew Rausch's co-authors include Stephen Quinn, John G. Tew, Harvey A. Schenkein, John C. Gunsolley, Jonathan A. Hill, Devapregasan Moodley, Pamela M. Holland, Kerry White, Vito J. Palombella and Katherine H. Walsh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Infection and Immunity.

In The Last Decade

Matthew Rausch

11 papers receiving 53 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Rausch United States 5 35 17 15 8 5 11 54
Lion F. K. Uhl United Kingdom 4 55 1.6× 20 1.2× 3 0.2× 16 2.0× 3 0.6× 6 82
M. Živković United States 3 15 0.4× 8 0.5× 5 0.3× 8 1.0× 3 0.6× 6 62
Tao Suo China 2 20 0.6× 4 0.2× 3 0.2× 24 3.0× 2 0.4× 5 58
Charlotte Thompson United Kingdom 5 21 0.6× 18 1.1× 1 0.1× 14 1.8× 3 0.6× 9 75
Camille Knosp United Kingdom 2 37 1.1× 16 0.9× 10 1.3× 4 0.8× 2 58
Shaimaa El‐Ashwah Egypt 4 19 0.5× 22 1.3× 10 1.3× 8 1.6× 31 55
Alba de Pablo García‐Cuenca Spain 2 6 0.2× 12 0.7× 29 1.9× 22 2.8× 2 0.4× 4 60
Meghan E. Bushway United States 5 53 1.5× 40 2.4× 26 3.3× 4 0.8× 8 78
Junli Wang China 4 22 0.6× 11 0.6× 1 0.1× 19 2.4× 2 0.4× 11 49
Gabriela Steiner United States 3 25 0.7× 31 1.8× 20 2.5× 2 0.4× 6 62

Countries citing papers authored by Matthew Rausch

Since Specialization
Citations

This map shows the geographic impact of Matthew Rausch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Rausch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Rausch more than expected).

Fields of papers citing papers by Matthew Rausch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Rausch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Rausch. The network helps show where Matthew Rausch may publish in the future.

Co-authorship network of co-authors of Matthew Rausch

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Rausch. A scholar is included among the top collaborators of Matthew Rausch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Rausch. Matthew Rausch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Aldridge, Daniel L., Devapregasan Moodley, Jeongho Park, et al.. (2024). Endogenous IL-27 during toxoplasmosis limits early monocyte responses and their inflammatory activation by pathological T cells. mBio. 15(3). e0008324–e0008324. 4 indexed citations
2.
Ren, Xiaoxin, Austin Dulak, Matthew Rausch, et al.. (2022). 489 NPX267, a first-in-class monoclonal antibody targeting KIR3DL3, blocks HHLA2-mediated immunosuppression and potentiates T and NK cell-mediated antitumor immunity. Regular and Young Investigator Award Abstracts. A510–A510. 5 indexed citations
3.
Moodley, Devapregasan, Austin Dulak, Ricard Masia, et al.. (2021). Abstract 1802: CD39 inhibition shapes the transcriptional landscape of myeloid cells and induces proinflammatory states in the CT26 syngeneic tumor model. Cancer Research. 81(13_Supplement). 1802–1802. 2 indexed citations
4.
Koseoglu, Secil, Ricard Masia, Matthew Rausch, et al.. (2021). 247 The fully human antibody SRF617 is a potent inhibitor of ecto-enzyme CD39 in vivo. Regular and Young Investigator Award Abstracts. A267–A267. 1 indexed citations
5.
6.
Rausch, Matthew, Devapregasan Moodley, Secil Koseoglu, et al.. (2020). 727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors. SHILAP Revista de lepidopterología. A435.1–A435. 1 indexed citations
7.
White, Kerry, Matthew Rausch, Jing Hua, et al.. (2019). Abstract 558: MERTK-specific antibodies that have therapeutic antitumor activity in mice disrupt the integrity of the retinal pigmented epithelium in cynomolgus monkeys. Cancer Research. 79(13_Supplement). 558–558. 7 indexed citations
8.
9.
Henau, Olivier De, Taha Merghoub, David A. Winkler, et al.. (2016). Abstract 554: Checkpoint blockade therapy is improved by altering the immune suppressive microenvironment with IPI-549, a potent and selective inhibitor of PI3K-gamma, in preclinical models. Cancer Research. 76(14_Supplement). 554–554. 3 indexed citations
10.
Rausch, Matthew, Jeremy H. Tchaicha, Thomas T. Tibbitts, et al.. (2016). Abstract B032: The PI3K-γ inhibitor, IPI-549, increases antitumor immunity by targeting tumor-associated myeloid cells and remodeling the immune-suppressive tumor microenvironment. Cancer Immunology Research. 4(11_Supplement). B032–B032. 3 indexed citations
11.
Quinn, Stephen, et al.. (1996). Hyper-immunoglobulin G2 production by B cells from patients with localized juvenile periodontitis and its regulation by monocytes. Infection and Immunity. 64(6). 2004–2009. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lion F. K. Uhl Breakdown of academic impact, for papers by M. Živković Breakdown of academic impact, for papers by Tao Suo Breakdown of academic impact, for papers by Charlotte Thompson Breakdown of academic impact, for papers by Camille Knosp Breakdown of academic impact, for papers by Shaimaa El‐Ashwah Breakdown of academic impact, for papers by Alba de Pablo García‐Cuenca Breakdown of academic impact, for papers by Meghan E. Bushway Breakdown of academic impact, for papers by Junli Wang Breakdown of academic impact, for papers by Gabriela Steiner
Rankless by CCL
2026